NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

DCF Advisers, LLC's Holding History (CIK: 0001802493)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 160,600 Value ($000) $5,634 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 175,250 Value ($000) $4,984 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 172,500 Value ($000) $3,124 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 172,500 Value ($000) $3,531 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 89,400 Value ($000) $2,298 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 34,000 Value ($000) $564 Avg Close $17.30 Range $15.19 - $21.48

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	160,600	$5,634	$36.39	$28.19 - $42.00
Q3 2025	175,250	$4,984	$23.97	$17.97 - $28.91
Q2 2025	172,500	$3,124	$18.24	$14.06 - $22.25
Q1 2025	172,500	$3,531	$22.23	$17.18 - $26.80
Q4 2024	89,400	$2,298	$21.24	$15.51 - $27.29
Q3 2024	34,000	$564	$17.30	$15.19 - $21.48